Tetra Bio-Pharma (OTC: TBPMF) Provides Update on Its New Drug Submission Application in Canada
REDUVO would have Canada’s only Drug Identification Number for a THC-based prescription drug The addressable market is estimated to be $80M CDN by 2022 OTTAWA, ON / April 14, 2021 / Tetra Bio-Pharma Inc. (“Tetra” or […]
